Furthermore, it was found that the CCR9+ subpopulation of pDCs produce less type I IFN than CCR9- pDCs (56) and CCR9+ pDCs can induce more immunosuppressive Tregs in graft-versus-host disease models (57). This evidence concerns the gene CCR9 and graft versus host disease.